Otsuka To Bolster Drug Pipeline With $3.5B Avanir Buy
Japan's Otsuka Pharmaceutical Co. Ltd. said Tuesday it plans to buy California drugmaker Avanir Pharmaceuticals Inc. for $3.5 billion in cash, deepening its penetration of the American market and refreshing its...To view the full article, register now.
Already a subscriber? Click here to view full article